Skip to main content
. Author manuscript; available in PMC: 2014 Nov 19.
Published in final edited form as: Endocr Pract. 2009 Apr;15(3):234–239. doi: 10.4158/EP.15.3.234

Fig. 1.

Fig. 1

Course of serum calcium levels in a patient with metastatic renal cell carcinoma and simultaneous elevation in serum parathyroid hormone–related peptide and 1,25-dihydroxyvitamin D before and during bisphosphonate and glucocorticoid therapy. Shaded area represents reference range for serum calcium. Arrows represent timing of 90-mg pamidronate intravenous infusions. Bisphosphonate therapy was ineffective in treating the hypercalcemia, but resolution occurred with glucocorticoids.